Back to Authors
https://orcid.org/0000-0002-9259-2984
Mayo Clinic
GlaxoSmithKline (United States)
Future Rare Diseases | November 10, 2023 | Volume: 4 | Issue: 1 | Pages: No page available
10.2217/frd-2023-0016